Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Identify compelling low-cost index funds for retirement by evaluating tracking error, fees, and diversification. Build a lineup aligned with long-term goals.
27,243 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
A young plaintiff testifies in a civil trial accusing major platforms of harming mental health, focusing on a compuls...
Evaxion's Q1 2026 results shed light on how its AI-driven drug discovery model is translating into collaborations and...
The ripple (xrp) price down narrative dominates crypto desks as XRP slides toward $1 amid a market-wide pullback. Her...
Meta documents reveal plans to launch an AI-powered prediction market app using play money. The move could reshape ho...
As AMD gears up for its Aug. 4 earnings release, the stock’s unstoppable momentum raises questions: what would truly ...
Tesla stock has slid about 18% from its December peak as deliveries declined and autonomy safety metrics raise questi...
A former battery designer explains how America can reclaim global leadership by building next-gen materials on domest...
Forecasters warn the 2026 El Niño could be one of the strongest on record, risking broad economic shocks and volatile...
Stocks and exchange-traded funds tied to PayPal surged after Reuters reported Stripe and Advent International were we...
UPS sinks about 11% after weaker quarterly results, while FedEx surges past UPS in market value following a stronger ...
CVS Health posts a robust Q1 driven by Aetna, lifting guidance and reigniting investor optimism. The market now weigh...